Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 13, Issue 23
|
pp. 25089–25105
The isoflavone puerarin exerts anti-tumor activity in pancreatic ductal adenocarcinoma by suppressing mTOR-mediated glucose metabolism
Back to article
Figure 8
(8 of 8)
−
100%
+
Figure 8.
Puerarin suppresses oncogenesis and progression of PDAC via suppressing Akt/mTOR activity.